Change language dansk English suomi svenska

Generate Estimates Confirm Cancel Hide empty rows Show hidden rows DummyText

CODAN MEDICAL ApS Estimate generation in progress, please wait... 0%

Quicksearch from your own companies XBRLDenmark Analyst: XBRLDenmark

Loading... Loading... Loading... Loading...   Loading...

1000.0 Bankruptcy Risk  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Bankruptcy risk for industry   1.5% 1.5% 1.5% 1.5% 1.5% 1.5% 2.2% 2.2%   Bankruptcy risk   0.4% 0.5% 0.5% 0.5% 0.6% 1.3% 6.9% 6.7%   Credit score (0-100)   100 99 99 99 98 79 35 36   Credit rating   AAA AAA AA AAA AA A BBB BBB   Credit limit (kDKK)   8,704.2 10,009.9 14,106.0 16,477.0 19,613.9 2,583.4 0.0 0.0   How are these values calculated?   View the automatically generated explanation of bankruptcy risk 1000.0 Income statement (kDKK)  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Gross profit   77,422 74,602 106,951 107,878 95,224 64,674 0.0 0.0   EBITDA   15,296 17,945 44,005 35,108 22,493 -498 0.0 0.0   EBIT   9,529 12,572 38,755 28,338 15,768 -7,024 0.0 0.0   Pre-tax profit (PTP)   9,552.2 12,497.3 38,498.7 28,189.0 15,729.2 -5,624.4 0.0 0.0   Net earnings   7,446.8 9,742.4 30,024.3 22,073.1 11,830.3 -4,411.2 0.0 0.0   Pre-tax profit without non-rec. items   9,552 12,497 38,499 28,189 15,729 -5,624 0.0 0.0     See the entire income statement 1000.0 Balance sheet (kDKK)  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Tangible assets total   29,119 29,552 34,170 31,871 26,892 24,015 0.0 0.0   Shareholders equity total   60,724 70,466 100,491 122,564 134,394 129,983 89,778 89,778   Interest-bearing liabilities   653 2,336 718 73.0 836 1,187 0.0 0.0   Balance sheet total (assets)   74,829 84,328 124,529 143,127 148,163 138,552 89,778 89,778   Net Debt   -12,293 -17,193 -8,176 -20,209 -79,745 -82,123 -89,778 -89,778     See the entire balance sheet 1000.0 Volume  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Net sales growth   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Gross profit   77,422 74,602 106,951 107,878 95,224 64,674 0.0 0.0   Gross profit growth   -6.5% -3.6% 43.4% 0.9% -11.7% -32.1% -100.0% 0.0%   Employees   171 150 150 171 165 152 0 0   Employee growth %   -11.4% -12.3% 0.0% 14.0% -3.5% -7.9% -100.0% 0.0%   Employee expenses   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   74,829 84,328 124,529 143,127 148,163 138,552 89,778 89,778   Balance sheet change%   7.9% 12.7% 47.7% 14.9% 3.5% -6.5% -35.2% 0.0%   Added value   15,296.4 17,945.1 44,004.9 35,107.9 22,538.5 -497.8 0.0 0.0   Added value %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Investments   -3,404 -4,786 -704 -9,140 -11,715 -9,403 -24,015 0   Net sales trend   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   EBIT trend   3.0 4.0 5.0 5.0 5.0 -1.0 0.0 0.0   1000.0 Profitability  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A EBITDA %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT to gross profit (%)   12.3% 16.9% 36.2% 26.3% 16.6% -10.9% 0.0% 0.0%   Net Earnings %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Profit before depreciation and extraordinary items %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Pre tax profit less extraordinaries %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   ROA %   13.3% 15.8% 37.1% 21.2% 10.9% -3.9% 0.0% 0.0%   ROI %   16.1% 18.6% 44.3% 25.2% 12.3% -4.2% 0.0% 0.0%   ROE %   13.1% 14.9% 35.1% 19.8% 9.2% -3.3% 0.0% 0.0%   1000.0 Solidity  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Equity ratio %   81.2% 83.6% 80.9% 85.6% 90.9% 93.8% 100.0% 100.0%   Relative indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Relative net indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net int. bear. debt to EBITDA, %   -80.4% -95.8% -18.6% -57.6% -354.5% 16,496.3% 0.0% 0.0%   Gearing %   1.1% 3.3% 0.7% 0.1% 0.6% 0.9% 0.0% 0.0%   Net interest   0 0 0 0 0 0 0 0   Financing costs %   3.0% 7.5% 16.8% 37.6% 43.6% 0.1% 0.0% 0.0%   1000.0 Liquidity  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Quick Ratio   2.7 3.5 3.5 5.0 8.1 11.8 0.0 0.0   Current Ratio   3.4 4.1 3.8 5.5 8.8 13.4 0.0 0.0   Cash and cash equivalent   12,945.9 19,529.2 8,893.8 20,281.6 80,581.2 83,309.4 0.0 0.0   1000.0 Capital use efficiency  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Trade debtors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Trade creditors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Current assets / Net sales %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net working capital   32,072.6 41,341.0 66,641.3 91,180.6 107,501.5 105,968.0 0.0 0.0   Net working capital %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   1000.0 Employee efficiency  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales / employee   0 0 0 0 0 0 0 0   Added value / employee   89 120 293 205 137 -3 0 0   Employee expenses / employee   0 0 0 0 0 0 0 0   EBITDA / employee   89 120 293 205 136 -3 0 0   EBIT / employee   56 84 258 166 96 -46 0 0   Net earnings / employee   44 65 200 129 72 -29 0 0